This is the text extract for PHARMAC Forum 09 - Generic Medicines and Brand Changes.ppt, browse documents here.
Generic Medicines and Brand Changes
Mike Bignall Therapeutic Group Manager
Life cycle of a medicine
Time
Research & Development
Patent Life
Generic Entry
Generics = large price reductions
Product Pioglitazone Baclofen Fluconazole (200 mg) Buspirone (10 mg) Fluconazole (50 mg) Propranolol Buspirone (5 mg) Selegiline Doxycycline Pindolol Use/disease treated Type 2 diabetes Muscle relaxant Fungal infections Anti-anxiety Fungal infections Heart disease Anti-anxiety Parkinsons disease Antibiotic Heart disease Price reduction 93 - 96% 93.6% 93.4% 90.8% 90.8% 88.2% 83.4% 82.2% 82.0% 80.9%
Case Study – Fluconazole 200 mg (per pack)
$628
$1.9 million $41.50
1993 2005
$19.05
2009
International Use of Generics
60
volume of generics (%)
50 40 30 20 10 0
U K ia U SA us tr al ad a al a N ew Ze nd
OECD Health Policy Studies, Pharmaceutical Pricing Policies in a Global Market (www.oecd.org.nz) released September 2008.
A
C
an
•$70
• from
million
in 2009
•saved
generic competition
It has to be safe and effective
•
Careful Choices
• • • • • •
Internal analysis and consideration on products Wide consultation Objective clinical advice Tender issued Tender Evaluation Final consideration and approval
Patient information
Generic Medicines – Health Professional Series
Generic Medicines & Brand Changes
Monitoring brand changes
• • • •
Direct communication to PHARMAC Public comment Direct relationships with health professionals CARM
Key findings of consumer research
High general awareness of generic medicines Key role of doctors and pharmacists Experience with generic medicines reduces anxieties Less than 1/3 of people received information
4 out of 5 consumers want:
Information about NZ quality and safety checks Evidence core ingredients are the same Information about the effectiveness of the generic medicine
5%
Consumers PHARMAC Pharmacists
Improving Brand Changes Medsafe Prescribers Industry
Metadata
Title
PHARMAC Forum 09 - Generic Medicines and Brand Changes.ppt
Abstract
Generic Medicines and Brand Changes Mike Bignall Therapeutic Group Manager Life cycle of a medicine Time Research & Development Patent Life Generic Entry Generics = large price reductions Product Pioglitazone Baclofen Fluconazole (200 mg) Buspirone (10 mg) Fluconazole (50 mg)…
Page 1
Note
This text has been extracted from the source PDF document.
Also available as plain text.
Please contact webmaster to discuss alternative format options.
